Free weekly newsletter

Get the free weekly executive digest

The new leadership moves, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.

Weekly Digest

New leadership moves, summarized for you

Straight to Inbox

No login, no app to check — it comes to you

Leadership Trends

See who's moving and how much in your market

No credit card required Weekly executive digest

Charm Therapeutics Appoints Dr Beverley Carr As Chief Business Officer

PRIVATESep 10, 2024•almost 2 years ago

Position

Chief Business Officer

Company

CHARM Therapeutics

Beverley Carr

LondonBiotechnologyHealthcareHealth Care

Description

CHARM Therapeutics appoints Dr Beverley Carr as Chief Business Officer. Highly experienced dealmaker to lead CHARM’s business development and drive strategic value from CHARM’s leading protein-ligand intelligence platform.

Company Information

Company

CHARM Therapeutics

Location

London, England, United Kingdom

About

CHARM Therapeutics is discovering and developing small molecule medicines against difficult-to-drug targets with our proprietary 3D deep learning-enabled platform, DragonFold. Powered by the first high throughput protein-ligand co-folding algorithm and a world-class team of scientists and engineers, CHARM seeks to deliver innovative approaches to create life-changing therapies for patients.

Related People

Suggested for you

Choose your plan to reveal verified contacts

Predictive Intelligence

Strategic

ML-powered predictions for CHARM Therapeutics's next move

Learn about Strategic plan

Executive Insights

Based on hiring data

New executive impact window

87% of new executives make significant technology decisions within first 100 days

Budget influence

C-level executives control 73% of technology spending decisions

Transformation catalyst

65% of new senior hires launch digital transformation initiatives

Vendor review timeline

New executives typically review existing vendors within 6 months